BioScrip Inc. is in talks with lenders to reduce debt leverage requirements of a 2013 credit agreement.

If successful, the company will have immediate access to $15 million in incremental liquidity. The amendment will not affect the revolving credit facility's maturity date of July 31, 2018.

BioScrip is implementing a turnaround strategy for the business.